Balchem Co. (NASDAQ:BCPC) Shares Sold by Commerce Bank

Commerce Bank cut its position in Balchem Co. (NASDAQ:BCPC) by 2.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,802 shares of the basic materials company’s stock after selling 105 shares during the quarter. Commerce Bank’s holdings in Balchem were worth $845,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its position in Balchem by 129.7% in the 3rd quarter. Victory Capital Management Inc. now owns 98,853 shares of the basic materials company’s stock valued at $17,398,000 after buying an additional 55,822 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in Balchem by 32.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 193,146 shares of the basic materials company’s stock worth $29,929,000 after purchasing an additional 47,036 shares during the period. Congress Asset Management Co. raised its position in Balchem by 12.4% in the 3rd quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock valued at $53,053,000 after purchasing an additional 33,373 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in shares of Balchem by 2.7% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,155,209 shares of the basic materials company’s stock valued at $177,844,000 after buying an additional 29,825 shares during the period. Finally, Fiera Capital Corp acquired a new position in shares of Balchem during the third quarter worth about $4,201,000. 87.91% of the stock is currently owned by hedge funds and other institutional investors.

Balchem Trading Up 0.1 %

NASDAQ:BCPC opened at $182.69 on Tuesday. Balchem Co. has a 1 year low of $120.87 and a 1 year high of $186.03. The stock has a market cap of $5.94 billion, a P/E ratio of 49.11, a P/E/G ratio of 5.45 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The stock has a 50-day simple moving average of $173.84 and a 200-day simple moving average of $166.71.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. HC Wainwright raised their target price on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.